文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

宫颈癌CT模拟定位增强扫描致危及器官剂量偏高的非预期后果

Higher Dose to Organs at Risk: The Unintended Consequences of Intravenous Contrast Use in Computed Tomography Simulation for Cervical Cancer.
PubMed 文献 · Pract Radiat Oncol · 2021-08-19

本研究回顾性分析20例接受预防性扩大野放疗的宫颈癌患者,每例均行平扫与增强模拟定位扫描并基于两种扫描制定放疗计划。增强扫描下下腔静脉体积平均扩大44%,腹主动脉旁淋巴结临床靶区体积平均增加17%,且十二指肠和右肾剂量显著更高。提示增强扫描可导致靶区过度勾画和危及器官过量照射。

要点

  • 增强扫描下下腔静脉体积平均扩大44%,腹主动脉旁淋巴结CTV体积平均增加17%。
  • 增强扫描下十二指肠第二段和第三段多个V剂量参数显著高于平扫。
  • 增强扫描下右肾V5至V25均显著高于平扫。

核心结论

  • 增强扫描下下腔静脉扩张可导致宫颈癌预防性扩大野放疗中靶区过度勾画和十二指肠、右肾过量照射。

研究设计与样本

  • 回顾性分析2021年3月至4月北京协和医院20例接受预防性扩大野放疗的宫颈癌患者,每例均行平扫和增强模拟定位扫描并基于两种扫描勾画结构、制定放疗计划,采用Student t检验和Pearson相关系数检验。

主要发现

  • 增强扫描较平扫下腔静脉平均体积扩大44%(P ≤ .001),腹主动脉旁淋巴结临床靶区平均体积增加17%(P ≤ .001)。
  • 十二指肠第二段V30、V35、V40、V45、V50在平扫均显著低于增强扫描(38.2% vs 43.8%,P = .038;27.6% vs 35.1%,P = .002;18.3% vs 26.3%,P = .014;11.2% vs 18.5%,P = .008;4.2% vs 9.1%,P = .005)。
  • 十二指肠第三段V45和V50在平扫均显著低于增强扫描(78.4% vs 81.6%,P = .03;59.7% vs 67%,P ≤ .001)。
  • 右肾V5、V10、V15、V20、V25在增强扫描与平扫分别为85.4% vs 79.8%(P = .013)、52.5% vs 45.6%(P = .021)、25.6% vs 20.1%(P = .003)、11.1% vs 7.5%(P = .001)、3.8% vs 2.3%(P = .027)。

临床怎么用

  • 宫颈癌预防性扩大野放疗模拟定位时需注意增强扫描下下腔静脉扩张对靶区勾画和危及器官剂量的影响。

局限性

  • 本研究为单中心回顾性分析,样本量20例,结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the volumes of interest and doses to the organs at risk on contrast and noncontrast scans in patients with cervical cancer who underwent prophylactic extended-field radiation therapy (EFRT). METHODS AND MATERIALS: We reviewed twenty cervical cancer patients treated with prophylactic EFRT at Peking Union Medical College Hospital between March 2021 and April 2021. Each patient underwent noncontrast and contrast scans during simulation. All structures were contoured, and radiation therapy plans were created based on both scans. Student t test and Pearson correlation coefficient test were performed. RESULTS: Compared with the noncontrast scan, on the contrast scan, the mean volume of the inferior vena cava expanded by 44% (P ≤ .001), and the mean volume of the para-aortic nodal clinical target volume increased by 17% (P ≤ .001). For the second portion of the duodenum, the V30 (38.2% vs 43.8%, P = .038), V35 (27.6% vs 35.1%, P = .002), V40 (18.3% vs 26.3%, P = .014), V45 (11.2% vs 18.5%, P = .008), and V50 (4.2% vs 9.1%, P = .005) were significantly lower on the noncontrast scan than on the contrast scan. For the third portion of the duodenum, the V45 (78.4% vs 81.6%, P = .03) and V50 (59.7% vs 67%, P ≤ .001) were significantly lower on the noncontrast scan than on the contrast scan. For the right kidney, the V5, V10, V15, V20, and V25 on the contrast and noncontrast scans were 85.4% versus 79.8% (P = .013), 52.5% versus 45.6% (P = .021), 25.6% versus 20.1% (P = .003), 11.1% versus 7.5% (P = .001), and 3.8% versus 2.3% (P = .027), respectively. CONCLUSIONS: Compared with the noncontrast scan, expansion of the inferior vena cava on the contrast scan can lead to excessive contouring and an overdose to the duodenum and right kidney in cervical cancer patients treated with prophylactic EFRT.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Wang D, Yang B, Wang W, et al. Higher Dose to Organs at Risk: The Unintended Consequences of Intravenous Contrast Use in Computed Tomography Simulation for Cervical Cancer. Pract Radiat Oncol. 2021. PMID: 34419624. doi:10.1016/j.prro.2021.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。